Vertex Pharma scientist talks about the long road to developing non
Release time：2024-05-22 03:19:37 Source：Culture Corner news portal
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
- Previous：Trump film shocks Cannes as former US President is depicted 'raping' his then
- Next：Target starts price war with Walmart by slashing the cost of 5,000 popular items
Related articles
- Dodgers acquire pitcher Yohan Ramírez from Mets for cash
- China's growth spurs optimism
- China remains world's largest engine for growth
- I'm a career expert
- Election 2024: Biden and Trump bypassed the Commission on Presidential Debates
- German agribusiness giant Bayer confident in China's seed industry
- Aviation hub drives Beijing
- China's PPI down 2.7 pct in February
- What a blast to work at NASA. Space agency is sky
- CPEC hydropower station starts impoundment in NW Pakistan
- With Djokovic awaiting the winner, Murray trails Hanfmann at rain
- Black sailor killed at Pearl Harbor FINALLY identified more than eight decades after 19
- Liam Ohgren scores his 1st career goal to lead the Wild past the Sharks 6
- China’s unemployment rate for youth aged 16
- A warrant for Netanyahu’s arrest was requested. But no decision was made about whether to issue it
- China pledges proactive fiscal policy, prudent monetary policy in 2024
- Chinese carriers allowed to operate more flights to US
- REVEALED: The US cities where home prices have DOUBLED the fastest
- Tourism boosts China's social, economic development
- China's fiscal budget well implemented in 2023
Random recommendation
- Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,Culture Corner news portal sitemap